14
HEALTH CARE DATA IN SAUDI ARABIA: CHALLENGES IN COLLECTING, SHARING, AND APPLYING Mohammed Al-Kelya MS, PhD Vice President, ISPOR Saudi Arabia Chapter and Head Quality Management, KAIMRC Riyadh, Kingdom of Saudi Arabia & Abdulaziz Al-Saggabi, MSc, PharmD President, ISPOR Saudi Arabia Chapter and Director, Drug Policy & Economics Center, NGHA Riyadh, Kingdom of Saudi Arabia

HEALTH CARE DATA IN SAUDI ARABIA: CHALLENGES IN COLLECTING ... · HEALTH CARE DATA IN SAUDI ARABIA: CHALLENGES IN COLLECTING, SHARING, AND APPLYING Mohammed Al-Kelya MS, PhD Vice

Embed Size (px)

Citation preview

HEALTH CARE DATA IN SAUDI ARABIA: CHALLENGES IN COLLECTING, SHARING, AND

APPLYING

Mohammed Al-Kelya MS, PhD Vice President, ISPOR Saudi Arabia Chapter and

Head Quality Management, KAIMRC Riyadh, Kingdom of Saudi Arabia

&

Abdulaziz Al-Saggabi, MSc, PharmD President, ISPOR Saudi Arabia Chapter and

Director, Drug Policy & Economics Center, NGHA Riyadh, Kingdom of Saudi Arabia

Health Care System In Saudi Arabia

“Every Saudi citizen has the right to have access to free medical services and no one should be denied medical attention because of economic reason”

2

Health Care System Indicators

28376355 Population

2.86(%) Population 65 Years Old & Above

24700 Gross National Income Per Capita (PPP Int. $)

3.69 Total Expenditure On Health As A Percentage Of Gross Domestic Product

68.93 (%) General Government Expenditure On Health As A Percentage Of Total Expenditure On Health

31.07(%) Private Expenditure On Health As A Percentage Of Total Expenditure On Health

19.37(%) Private Prepaid Plans As A Percentage Of Private Expenditure On Health

6.84(%) Percentage of government budget allocated to Health Service

58.06(%) Out-of-pocket Expenditure As A Percentage Of Private Expenditure On Health

71% Governmental Insured Population

29% Population Insured by Private Health Insurance

3

Saudi Health Care System Delivery

4

Provider

Affiliation Providers

Hospital

N (%)

Beds

N (%)

PHC or

centers

Visits Per

Year

N (%)

( Millions)

Annual

Admissions

N (%)

(In 1000)

Governmental

MOH 251 34450

(58.9) 2109 65.97 (50.0)

1700.18

(56.2)

KAUH,R

KKUH,R

KFUH,K

RCHs

AHF

KFSH,R

NGHs

SFH

KFSH,J

ARAMCO Hs

39 10948

(20.0) NA 23.15 (17.6) 519.16(17.1)

Private Private sectors 130 13298

(21.1)

2185

polyclinic

198 clinics

42.73 (32.4) 808.24 (26.7)

Total 420 (100) 58696(100) 131.86 (100) 3027.58(100)

Provider Affiliation Providers Eligibility Type of Drug

Formulary

Governmental

MOH Saudi citizen and Resident Closed

M.O. Defense Employees & their dependents

Closed & More Generous than

MOH National Guard

Ministry of Interior Referred Cases Free Of charge,

FFS for self referral

Higher Educations Employee, student, referred

cases (free)

Similar to MOH

Closed

Public Education & others Employee, student, Less than MOH

Closed

Semi –governmental

Governmental industrial

institutions Employees & their dependent

More generous Closed

Governmental insurance

hospitals

Open formulary

Out of pocket

Private Private sectors FFS Open formulary

Out of pocket

Total

Saudi Health Care Services Providers, Beneficiaries and Type of Drug Formulary

5

Barriers and

Opportunities

Publication Increase

7

0

5

10

15

20

25

30

35

40

45

2009 2010 2011 2012

Fr

Year

Publication Trend of QOL related Studies in Saudi Arabia

Article

Confernce Abstract

Web of Science Database (ISI)

– Thromboembolic Disorders Registry

– Venous Thrombosis Registry

– Cleft/Lip Palate & Craniofacial Disorders Registry

– National Family Safety Registry

– Pan Arab Liver Transplantation Registry

– Rare Dental Disorder Registry

– Chronic Diseases Registry

– Organ Transplantation Registry

– Saudi Bio-bank

– Trauma Registries

Registries

8

– Saudi National Diabetes Registry – Saudi Cancer Registry – National Congenital Heart Defects Registry – National Epilepsy Registry – Neural Tube Defects Registry

– Neuromuscular Disease Registry – Primary Immunodeficiency Registry

Registries…(continued)

9

Clinical Studies in Saudi Arabia

10 http://www.clinicaltrials.gov/

PE Study Enablers

Demand for PE Studies

PE Research

Teams Data

Demands for PE Studies in Saudi Arabia

Health Care

providers Awareness.

PE Guidelines by Regulatory

Body. Awareness of Policy Makers in Health Care Organizations.

Evidence base medicine focused.

Focus on cost containment not CE.

Data for PE Studies in Saudi Arabia

Cost lists -MOH Medical procedures price lists(fixed price) -SFDA Drug Price List

Clinical Data -Local Clinical

Studies -Registries -Hospital Data

Claims Data -Health Insurance Companies -CCHI

MOH list can be used as proxy for the cost across all Saudi hospitals

-Data is not standardized yet -Will be By 2014

-Accessibility -Standardization -Data usability

PE Research Team

Institutionalization -Only few local PE Centers - No Entity at national level responsible for TA

Human Capacity -No educational program -Few training programs

Integration -Building database all PE hospital studies -Sharing expertise and

data

Not equipped with all capabilities and focus at institution level

-No formal networking connecting experts and outcomes of their efforts. -Unsustainable training

-Short training programs